Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
about
Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d status.Vitamin D postpones the progression of epithelial ovarian cancer induced by 7, 12-dimethylbenz [a] anthracene both in vitro and in vivo.Surrogates of long-term vitamin d exposure and ovarian cancer risk in two prospective cohort studiesPeri- and post-menopausal incidental adnexal masses and the risk of sporadic ovarian malignancy: new insights and clinical management.Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization studyVitamin D and VDR in Gynecological Cancers-A Systematic Review.
P2860
Q33942599-F7E4AE9C-422C-409B-A8E4-F59963A17CE6Q34368796-6D8B5A61-2A89-4FD8-AF93-54F9F1F00B7CQ36838787-7430BFDE-75F6-4165-8835-BCD86EB10BD4Q37420609-CA3D3A29-4BA8-4148-9E64-6E9D60C11345Q37760524-2E88C922-1363-4247-882B-E32D55292CEEQ39423088-ACF105F3-BADF-4EDA-8B67-CD1FF752A335Q47126398-04555103-8901-4938-91C9-DE767C6CBC61
P2860
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
@en
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
@nl
type
label
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
@en
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
@nl
prefLabel
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
@en
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
@nl
P2093
P50
P1476
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
@en
P2093
Helja-Marja Surcel
Matti Lehtinen
Paolo Toniolo
Pentti Tuohimaa
P304
P356
10.1016/J.EJCA.2009.08.002
P577
2009-08-25T00:00:00Z